1. Home
  2. CELU vs BRIA Comparison

CELU vs BRIA Comparison

Compare CELU & BRIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CELU
  • BRIA
  • Stock Information
  • Founded
  • CELU 2016
  • BRIA 2011
  • Country
  • CELU United States
  • BRIA Singapore
  • Employees
  • CELU N/A
  • BRIA N/A
  • Industry
  • CELU Biotechnology: Pharmaceutical Preparations
  • BRIA
  • Sector
  • CELU Health Care
  • BRIA
  • Exchange
  • CELU Nasdaq
  • BRIA NYSE
  • Market Cap
  • CELU 42.2M
  • BRIA 47.1M
  • IPO Year
  • CELU N/A
  • BRIA 2024
  • Fundamental
  • Price
  • CELU $1.61
  • BRIA $2.39
  • Analyst Decision
  • CELU
  • BRIA
  • Analyst Count
  • CELU 0
  • BRIA 0
  • Target Price
  • CELU N/A
  • BRIA N/A
  • AVG Volume (30 Days)
  • CELU 54.8K
  • BRIA 25.0K
  • Earning Date
  • CELU 12-06-2024
  • BRIA 05-15-2025
  • Dividend Yield
  • CELU N/A
  • BRIA N/A
  • EPS Growth
  • CELU N/A
  • BRIA N/A
  • EPS
  • CELU N/A
  • BRIA 92.24
  • Revenue
  • CELU $48,200,000.00
  • BRIA $59,695,825.00
  • Revenue This Year
  • CELU N/A
  • BRIA N/A
  • Revenue Next Year
  • CELU $233.89
  • BRIA N/A
  • P/E Ratio
  • CELU N/A
  • BRIA $0.03
  • Revenue Growth
  • CELU 225.94
  • BRIA 8.03
  • 52 Week Low
  • CELU $1.00
  • BRIA $1.78
  • 52 Week High
  • CELU $5.22
  • BRIA $4.38
  • Technical
  • Relative Strength Index (RSI)
  • CELU 49.49
  • BRIA N/A
  • Support Level
  • CELU $1.47
  • BRIA N/A
  • Resistance Level
  • CELU $1.77
  • BRIA N/A
  • Average True Range (ATR)
  • CELU 0.16
  • BRIA 0.00
  • MACD
  • CELU 0.01
  • BRIA 0.00
  • Stochastic Oscillator
  • CELU 63.04
  • BRIA 0.00

About CELU Celularity Inc.

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from bio-banking segment.

About BRIA BRILLIA INC

BrilliA Inc is engaged in business of sales and marketing of lingerie's products including bra, panty and body suit, mainly serving the American, European and other markets.

Share on Social Networks: